C14H26N2O8
Neat
350.37
Dihydroxyspectinomycin; 935756-69-7; 2RTU85RDA7; (2R, 3R, 4S, 4aS, 5aR, 6S, 7S, 8R, 9S, 9aR, 10aS)-2-Methyl-6, 8-bis(methylamino)decahydro-2H-pyrano(2, 3-b)(1, 4)benzodioxine-3, 4, 4a, 7, 9-pentol; (2R, 3R, 4S, 4aS, 5aR, 6S, 7S, 8R, 9S, 9aR, 10aS)-Octahydro-2-methyl-6, 8-bis(methylamino)-2H-pyrano(2, 3-b)(1, 4)benzodioxin-3, 4, 4a, 7, 9(10ah)-pentol; 2H-Pyrano(2, 3-b)(1, 4)benzodioxin-3, 4, 4a, 7, 9(10ah)-pentol, octahydro-2-methyl-6, 8-bis(methylamino)-, (2R, 3R, 4S, 4aS, 5aR, 6S, 7S, 8R, 9S, 9aR, 10aS)-; Spectinomycin dihydrochloride EP Impurity D; Spectinomycin EP Impurity D; UNII-2RTU85RDA7; Spectinomycin dihydrochloride pentahydrate impurity D [EP]; SPECTINOMYCIN DIHYDROCHLORIDE PENTAHYDRATE IMPURITY D [EP IMPURITY]; (2R, 3R, 4S, 4aS, 5aR, 6S, 7S, 8R, 9S, 9aR, 10aS)-2-methyl-6, 8-bis(methylamino)decahydro-2H-benzo[b]pyrano[2, 3-e][1, 4]dioxine-3, 4, 4a, 7 and 9-pentaol
(1R, 3S, 5R, 6R, 7S, 8S, 10R, 11S, 12S, 13R, 14S)-5-methyl-11, 13-bis(methylamino)-2, 4, 9-trioxatricyclo[8.4.0.03, 8]tetradecane-6, 7, 8, 12 and 14-pentol
InChI=1S/C14H26N2O8/c1-4-7(17)12(20)14(21)13(22-4)23-11-9(19)5(15-2)8(18)6(16-3)10(11)24-14/h4-13,15-21H,1-3H3/t4-,5-,6+,7+,8+,9+,10-,11-,12+,13+,14+/m1/s1